Tuis600812 • SHA
add
North China Pharmaceutical Co Ltd
Vorige sluiting
¥5,40
Dagwisseling
¥5,45 - ¥5,65
Jaarwisseling
¥3,83 - ¥6,22
Gemiddelde volume
24,00 m
P/V-verhouding
119,06
Dividend-opbrengs
0,18%
Primêre beurs
SHA
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CNY) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 2,33 mjd | -15,04% |
Bedryfskoste | 539,22 m | -19,20% |
Netto inkomste | 30,48 m | 2 035,14% |
Netto winsgrens | 1,31 | 2 520,00% |
Wins per aandeel | — | — |
EBITDA | 362,65 m | 6,65% |
Effektiewe belastingkoers | 32,92% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(CNY) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 1,72 mjd | 15,99% |
Totale bates | 21,71 mjd | 0,92% |
Totale aanspreeklikheid | 15,10 mjd | -0,95% |
Totale ekwiteit | 6,61 mjd | — |
Uitstaande aandele | 1,72 mjd | — |
Prys om te bespreek | 1,73 | — |
Opbrengs op bates | 2,06% | — |
Opbrengs op kapitaal | 2,47% | — |
Kontantvloei
Netto kontantverandering
(CNY) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 30,48 m | 2 035,14% |
Kontant van bedrywe | 175,21 m | -46,70% |
Kontant van beleggings | -153,19 m | 10,80% |
Kontant van finansiering | -76,80 m | 67,74% |
Netto kontantverandering | -55,38 m | 30,27% |
Beskikbare kontantvloei | -660,87 m | -459,21% |
Meer oor
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Gestig
20 Des. 1992
Werknemers
10 159